Literature DB >> 11978807

Cannabinoid addiction: behavioral models and neural correlates.

Rafael Maldonado1, Fernando Rodríguez de Fonseca.   

Abstract

The use of cannabis sativa preparations as recreational drugs can be traced back to the earliest civilizations. However, animal models of cannabinoid addiction allowing the exploration of neural correlates of cannabinoid abuse have been developed only recently. We review these models and the role of the CB1 cannabinoid receptor, the main target of natural cannabinoids, and its interaction with opioid and dopamine transmission in reward circuits. Extensive reviews on the molecular basis of cannabinoid action are available elsewhere (Piomelli et al., 2000; Schlicker and Kathmann, 2001).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978807      PMCID: PMC6758395          DOI: 20026358

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination.

Authors:  J L Wiley; B R Martin
Journal:  Pharmacol Biochem Behav       Date:  1999-11       Impact factor: 3.533

2.  A cannabinoid mechanism in relapse to cocaine seeking.

Authors:  T J De Vries; Y Shaham; J R Homberg; H Crombag; K Schuurman; J Dieben; L J Vanderschuren; A N Schoffelmeer
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

3.  Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.

Authors:  D J Mason; J Lowe; S P Welch
Journal:  Eur J Pharmacol       Date:  1999-08-13       Impact factor: 4.432

4.  Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys.

Authors:  J L Wiley; J W Huffman; R L Balster; B R Martin
Journal:  Drug Alcohol Depend       Date:  1995-11       Impact factor: 4.492

5.  A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

Authors:  E Valjent; R Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

6.  Behavioral sensitization to heroin by cannabinoid pretreatment in the rat.

Authors:  F E Pontieri; P Monnazzi; A Scontrini; F R Buttarelli; F R Patacchioli
Journal:  Eur J Pharmacol       Date:  2001-06-15       Impact factor: 4.432

Review 7.  Neurobiology of marijuana abuse.

Authors:  M E Abood; B R Martin
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

8.  Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system.

Authors:  T Rubino; G Patrini; M Parenti; P Massi; D Parolaro
Journal:  Brain Res Mol Brain Res       Date:  1997-03

9.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats.

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

View more
  58 in total

Review 1.  A behavioral/systems approach to the neuroscience of drug addiction.

Authors:  Francis J White
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 2.  Emerging roles for endocannabinoids in long-term synaptic plasticity.

Authors:  Gregory L Gerdeman; David M Lovinger
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

3.  Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

Authors:  Anna Castañé; Rafael Maldonado; Olga Valverde
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

Review 4.  Endocannabinoids and exercise.

Authors:  A Dietrich; W F McDaniel
Journal:  Br J Sports Med       Date:  2004-10       Impact factor: 13.800

5.  Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.

Authors:  S Tai; W S Hyatt; C Gu; L N Franks; T Vasiljevik; L K Brents; P L Prather; W E Fantegrossi
Journal:  Pharmacol Res       Date:  2015-09-08       Impact factor: 7.658

6.  Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats.

Authors:  Lina Yao; Krista McFarland; Peidong Fan; Zhan Jiang; Takashi Ueda; Ivan Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

7.  Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.

Authors:  Marcello Solinas; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 8.  Neurobiology of the adolescent brain and behavior: implications for substance use disorders.

Authors:  B J Casey; Rebecca M Jones
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-10-08       Impact factor: 8.829

9.  Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

Authors:  Maria Scherma; Valentina Satta; Roberto Collu; Maria Francesca Boi; Paolo Usai; Walter Fratta; Paola Fadda
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

10.  The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.

Authors:  Marco Bortolato; Gian Nicola Aru; Roberto Frau; Marco Orrù; Grant Christopher Luckey; Gianluca Boi; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.